Guidelines for Prescribing, Authorising and Dispensing - Australian ...
Guidelines for Prescribing, Authorising and Dispensing - Australian ...
Guidelines for Prescribing, Authorising and Dispensing - Australian ...
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
Cytotoxic (anti-neoplastic) drugs. Cytotoxic drugs include a wide range of<br />
therapeutic agents intended primarily <strong>for</strong> the treatment of cancer. They are highly<br />
toxic to cells, <strong>and</strong> many have proved to be carcinogens, mutagens or teratogens.<br />
Adverse health effects may result from occupational exposure, <strong>and</strong> appropriate risk<br />
management strategies should be implemented – see Appendix 8.<br />
Extemporaneous prescription/<strong>for</strong>mulation. A veterinary chemical preparation<br />
specially <strong>for</strong>mulated by a veterinarian or by a pharmacist on a veterinarian’s<br />
prescription <strong>for</strong> the treatment of a specific condition in an animal(s) under the<br />
veterinarian’s care. Such unregistered products may only be used in foodproducing<br />
species when the drug is compounded <strong>for</strong> treatment of an individual<br />
animal.<br />
General anaesthetics. Although not specifically prohibited by state/territory<br />
legislation, there are no legitimate indications to dispense injectable general<br />
anaesthetics in veterinary practice.<br />
Hormonal growth promotants (HGPs). Specific controls have been imposed by<br />
the <strong>Australian</strong> Pesticides <strong>and</strong> Veterinary Medicines Authority (APVMA) which<br />
require all suppliers of hormonal growth promotants, including veterinarians, to be<br />
licensed by the APVMA. Such licensed suppliers are subject to annual audits <strong>and</strong><br />
must obtain purchaser declaration <strong>for</strong>ms <strong>and</strong> keep detailed records of all HGP<br />
purchases <strong>and</strong> sales, <strong>and</strong> provide monthly sales returns.<br />
See http://www.apvma.gov.au/qa/hgp.shtml<br />
There are particular requirements if animal products are intended <strong>for</strong> export to the<br />
European Union – see<br />
http://www.affa.gov.au/content/output.cfm?ObjectID=13C0E15F-A8FB-45C4-<br />
9F908A2861C0C7F6&contType=outputs<br />
Natural products. Any product containing ingredients derived from natural sources<br />
that is administered to animals with claims of modifying health, production,<br />
per<strong>for</strong>mance or behaviour must be registered. Products containing<br />
glycosaminoglycan, chondroitin sulphate, glucosamine or similar substances<br />
(including shark cartilage, abalone or green-lipped mussel) are considered to be<br />
veterinary medicines.<br />
Prostagl<strong>and</strong>ins. Prostagl<strong>and</strong>ins present particular health hazards to humans <strong>and</strong><br />
administration by veterinarians is preferable. However if prostagl<strong>and</strong>ins are<br />
dispensed, it should only be to experienced operators, with clear instructions about<br />
h<strong>and</strong>ling precautions. State veterinary board directives on prostagl<strong>and</strong>in dispensing<br />
should be followed.<br />
Psychotropic drugs. Various registered (human) anti-depressants such as<br />
fluoxetine, selegiline <strong>and</strong> amitriptyline are now used to treat behavioural problems<br />
in dogs, cats, birds <strong>and</strong> horses. These are mostly ‘off-label’ uses, which must be<br />
carefully explained to clients – see section 22.5. In prescribing <strong>and</strong> dispensing<br />
these drugs, veterinarians also should be aware of the potential <strong>for</strong> illegal diversion<br />
to human use.<br />
Sedatives <strong>for</strong> clipping, shoeing, horse-breaking, deer velveting <strong>and</strong> other<br />
procedures per<strong>for</strong>med by non-veterinarians. Sedatives should be dispensed only<br />
AVA <strong>Prescribing</strong> <strong>and</strong> dispensing guidelines<br />
Version 1.0 February 2005<br />
Updated 02/09/08<br />
12